Spontaneous Coronary Reperfusion in STEMI After Pre‐Hospital Loading Dose of Triple Antithrombotic Therapy
Clinical Cardiology · 2026
DOI: 10.1002/clc.70418 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Cardiology, 2026. Verfasst von Pierre Alain Meunier und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, CHU Montpellier, Montpellier, France. Hauptthemen laut MEDLINE: Coronary Circulation, Emergency Medical Services, Fibrinolytic Agents, Heparin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University hospital of Montpellier, France.
Abstract (Originalsprache)
Background
To evaluate the incidence and prognosis of spontaneous coronary reperfusion in STEMI using pre‐hospital loading dose of P2Y12 inhibitors.
Methods
This prospective bi‐centric study included STEMI patients who referred for primary PCI from June 1, to November 1, 2022. All patients received before hospital admission loading dose of aspirin, heparin and P2Y 12 inhibitor. The primary outcome was incidence of spontaneous coronary reperfusion (TIMI 3 flow) before primary PCI. Major in‐hospital and 1‐year events were secondary outcomes.
Results
Within the study period, 263 patients were admitted with ongoing STEMI and 49 of them (18.6%) had spontaneous coronary reperfusion with no significant difference between loading dose of ticagrelor ( n = 226; 85.9%) or clopidogrel ( n = 27, 10.3%) and TIMI 3 flow ( n = 41; 18.1% vs. n = 7; 25.9%, p = 0.53; respectively). Peak of T‐hs troponin ( p < 0.001) and CRP ( p = 0.03) were significantly lower in the TIMI 3 group. In multivariate analysis, out‐of‐ hospital cardiac arrests were observed twice as often in the TIMI 3 group (16.33 vs. 7.01%; p = 0.044). There was no significant difference between the two groups regarding major in‐hospital ( p = 0.69) or 1‐year major events ( p = 0.20).
Conclusion
Spontaneous reperfusion at admission was observed in about 20% of STEMI patients who received a pre‐hospital loading dose of antithrombotic therapy including P2Y 12 inhibitors, and was associated with markers of decrease of infarct size. The significant increase of pre‐admission cardiac arrests observed in the TIMI 3 group could be specifically explored as it might be a concern regarding future pre‐hospital reperfusion therapy strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, CHU Montpellier, Montpellier, France.
- Department of Cardiology, CHU Nîmes, Nîmes, France.
- Epidemiological and Clinical Research Unit, CHU Montpellier, Montpellier, France.
ORCID-Profile: François Roubille, Benoit Lattuca, Florence Leclercq
Förderung
- University hospital of Montpellier, France
Zitieren
APA
Meunier, P. A., Juenin, L., Moulis, L., Roubille, F., Robert, P., Macia, J. C., Berdeu, J. M., Steinecker, M., Lattuca, B., Schmutz, L., Cornillet, L., Cayla, G., & Leclercq, F. (2026). Spontaneous Coronary Reperfusion in STEMI After Pre‐Hospital Loading Dose of Triple Antithrombotic Therapy. Clinical Cardiology. https://doi.org/10.1002/clc.70418
Vancouver
Meunier PA, Juenin L, Moulis L, Roubille F, Robert P, Macia JC, et al. Spontaneous Coronary Reperfusion in STEMI After Pre‐Hospital Loading Dose of Triple Antithrombotic Therapy. Clinical Cardiology. 2026. doi:10.1002/clc.70418
BibTeX
@article{Meunier2026,
author = {Meunier, Pierre Alain and Juenin, Lea and Moulis, Lionel and Roubille, François and Robert, Pierre and Macia, Jean Christophe and Berdeu, Jean-Michel and Steinecker, Matthieu and Lattuca, Benoit and Schmutz, Laurent and Cornillet, Luc and Cayla, Guillaume and Leclercq, Florence},
title = {Spontaneous Coronary Reperfusion in STEMI After Pre‐Hospital Loading Dose of Triple Antithrombotic Therapy},
journal = {Clinical Cardiology},
year = {2026},
doi = {10.1002/clc.70418}
}
EUVIMED